About the Authors
- Yinghong An
-
¶‡ These authors contributed equally to this work.
Affiliation Clinical Laboratory Center, Chinese PLA Air Force General Hospital, Haidian, Beijing 100142, PR China
- Wanjun Guo
-
¶‡ These authors contributed equally to this work.
Affiliation Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
- Linna Li
-
Affiliation Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
- Chengwang Xu
-
Affiliation Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
- Dexuan Yang
-
Affiliation Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
- Shanshan Wang
-
Affiliation Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
- Yaxin Lu
-
Affiliation College of Pharmacy, The State Key Laboratory of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, PR China
- Quan Zhang
-
Affiliation College of Pharmacy, The State Key Laboratory of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, PR China
- Jiadai Zhai
-
Affiliation College of Pharmacy, The State Key Laboratory of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, PR China
- Hongxia Fan
-
Affiliation College of Pharmacy, The State Key Laboratory of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300071, PR China
- Chuanjiang Qiu
-
Affiliation Accendatech Co., Ltd., Tianjin 300384, PR China
- Jie Qi
-
Affiliation Accendatech Co., Ltd., Tianjin 300384, PR China
- Yue Chen
-
* E-mail: yuansj@nic.bmi.ac.cn (SY) yuechenayh@163.com (YC)
Affiliation Accendatech Co., Ltd., Tianjin 300384, PR China
- Shoujun Yuan
-
* E-mail: yuansj@nic.bmi.ac.cn (SY) yuechenayh@163.com (YC)
Affiliation Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China
Competing Interests
Yue Chen is one of the founders of Accendatech Co., Ltd., which has a financial interest in DMAMCL. All other authors declare no competing financial interests. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: YA WG SY YC. Performed the experiments: YA WG LL YL QZ JZ. Analyzed the data: YA WG CX YL. Contributed reagents/materials/analysis tools: DY SW HF CQ JQ. Wrote the paper: YA.